Seems plenty already are
The immediate response has been significant, with both American and foreign companies accelerating investment initiatives across the U.S. Tech giants have been at the forefront of this movement, announcing billion-dollar investments to mitigate tariff impacts. Apple set the tone in February with a four-year, $500 billion investment pledge to construct a large factory in Texas that will produce advanced AI server equipment previously manufactured in China. In March, Taiwan Semiconductor Manufacturing announced a $100 billion investment to build five new semiconductor fabrication plants in the U.S., even though Trump has said he wants to end support to chip makers provided under the Biden-era Chips Act. Japan’s SoftBank Group committed $100 billion to support AI and tech ventures in the U.S. These investments reflect a strategic shift driven by tariffs and the promise of a more favorable domestic manufacturing environment.
The pharmaceutical industry also responded swiftly. Eli Lilly announced the largest pharmaceutical expansion investment in U.S. history, pledging $27 billion to build four large-scale plants. Amgen and Merck followed suit with significant investments in North Carolina, aimed at ramping up domestic production to mitigate potential disruption from proposed tariffs on imported medicines.
These moves underscore the urgency with which companies are adapting to the shift in trade policy under the new administration. Companies are prioritizing U.S.-based operations to secure their supply chains
https://www.barrons.com/articles/tru...urope-fa21ebd0